Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 03, 2026 17:00 ET | Source: Matinas BioPharma Holdings, Inc.

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

BEDMINSTER, N.J., April 03, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (the “Company”) (NYSE American: MTNB) announced today that on April 2, 2026, it received a notice (the “Notice”)...
April 03, 2026 17:00 ET | Source: Jena Acquisition Corporation II

Jena Acquisition Corporation II Announces Non-Compliance with Section 802.01B of the NYSE Listed Company Manual which Requires the Company to Maintain a Minimum of 300 Public Stockholders

LAS VEGAS, NEVADA., April 03, 2026 (GLOBE NEWSWIRE) -- Jena Acquisition Corporation II (the “Company”) announced today that on April 1, 2026, the Company received a written notice from the staff of...
April 03, 2026 16:55 ET | Source: Nail Refresh

Nail Refresh Claims Evaluated: The Strongest Natural Nail Fungus Relief Oil for Toenails Available

Nail Refresh Foot Fungus Oil 2026: biofilm-targeting botanical formula, ingredient research, Fungal Force Field claims, pricing, and key details.
April 03, 2026 16:30 ET | Source: Xilio Therapeutics, Inc.

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass., April 03, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for...
April 03, 2026 16:30 ET | Source: ORIC Pharmaceuticals

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 03, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that...
April 03, 2026 16:10 ET | Source: AEON Biopharma Inc

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
April 03, 2026 16:05 ET | Source: AEON Biopharma Inc

AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards

AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards
April 03, 2026 15:56 ET | Source: VitalRIZE

VitalRIZE Claims Evaluated: The Max Vitalize Virility Enhancement Support Supplement for Men

VitalRIZE male enhancement supplement for men over 45: ingredient research, pricing, refund policy, and consumer considerations for 2026.
April 03, 2026 15:52 ET | Source: Power Life

Power Life High Impact Plant Protein Claims Evaluated: The Cleanest Vegan Protein Powder on the Market by PowerLife

Power Life High Impact Plant Protein ingredients, HMB dosing, clean vegan protein claims, and pricing details covered in 2026 product overview.
April 03, 2026 15:05 ET | Source: RCM Technologies, Inc.

RCM Technologies, Inc. Announces Fourth Quarter And Fiscal Year 2025 Results

PENNSAUKEN, N.J., April 03, 2026 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of solutions designed to enhance the operational performance of its customers through...